ClinicalTrials.Veeva

Menu

Risk Factors and Predictive Model for Inflammatory Polyps in Ureteral Stones (UROLITH-POLYP)

J

Jilin University

Status

Completed

Conditions

Ureteral Calculi

Study type

Observational

Funder types

Other

Identifiers

NCT07559721
JLU-FH-2026-UROLITH-001

Details and patient eligibility

About

This is an observational studyincluding an internal retrospectivedevelopment cohort, an internalprospective temporal validation cohortand two external validation cohorts fromtwo independent external centers. Thestudy aims to identify independent riskfactors for inflammatory ureteral polypsin patients with ureteral calculi anddevelop a preoperative predictive model

Retrospective clinical and radiologicaldata were extracted from eligiblepatients treated from January 1, 2018to December 31, 2025 (n=874). Theprospective cohort consecutivelyenrolled participants from April 72026, to September 7, 2026 (n=162)Consecutive eligible patients from twoexternal centers were included forexternal validation (n=139 and n=176).The primary outcome is theintraoperative diagnosis of inflammatoryureteral polyps

Full description

This is a mixedretrospective-prospective observationalcohort study. The internal retrospectivedevelopment cohort (n=874) was fullyenrolled from January 1, 2018, toDecember 31, 2025, and was further splitinto a 70% training set and a 30%model-selection holdout set. Theinternal prospective temporal validationcohort consecutively enrolled eligibleparticipants from April 7, 2026, toSeptember 7, 2026 (n=162). Twoindependent external validation cohortsfrom two separate centers includedconsecutively enrolled patients withureteral calculi (n=139 and n=176)Preoperative clinical and radiologicaldata were collected to screenindependent risk factors and build apreoperative predictive model forinflammatory ureteral polyps. Theprimary endpoint was intraoperativediagnosis of inflammatory ureteralpolyps.

Enrollment

1,351 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 years or older undergoing ureteroscopic surgery for ureteral calculi at the First Hospital of Jilin University.
  • Complete clinical and imaging data available.

Exclusion criteria

  • Patients with bilateral ureteral calculi.
  • Patients with preoperative nephrostomy or indwelling ureteral stent.
  • Patients with a history of ureteral or bladder cancer.
  • Patients with congenital ureteral anomalies or previous ureteral surgery.
  • Patients with severe coagulation disorders or contraindications to ureteroscopy.
  • Patients unable to provide informed consent.

Trial design

1,351 participants in 2 patient groups

Model development cohort,
Description:
Model development cohort, including aninternal retrospective developmentsubset (Jan 1, 2018-Dec 31, 2025, n=874split into training and holdout set) andan internal prospective temporalvalidation subset (Apr 7, 2026-Sep 7,2026, n=162) from the First Hospital of Jilin University.
External validation cohort
Description:
External validation cohort, consisting of consecutively enrolled eligible patients with ureteral calculi retrospectively collected from two independent external centers: Shanghai Changhai Hospital (Jan 1 - Sep 11, 2026, n=139) and The Second Hospital of Tianjin Medical University (Jan 1 - Jul 31, 2026, n=176).

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems